|

Vasopressin Clinical Trials

7 actively recruiting trials across 3 locations

Also known as: Antidiuretic Hormone, Pitressin

Pipeline

Phase 2: 1Phase 4: 2

Top Sponsors

  • University of Electronic Science and Technology of China2
  • University of Chicago1
  • Thomas Jefferson University1
  • Samuel Lunenfeld Research Institute, Mount Sinai Hospital1
  • Jason Sperry1

Indications

  • Diabetes6
  • Shock2
  • Heart Disease2
  • Healthy2
  • Vasopressin Deficiency1

Other4 trials

Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study
N/A
Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study
N/A
Registry of Patients in Shock Treated With Vasopressin
The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study
N/A

Tucson, Arizona1 trial

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

University of Arizona

Phase 2

Chicago, Illinois1 trial

Vasoactive Drugs in Intensive Care Unit

University of Chicago Medical Center

Phase 4

Philadelphia, Pennsylvania1 trial

Low Dose Vasopressin vs Phenylephrine in Cardiac Surgery

Thomas Jefferson Univesity

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.